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Abstract
Background: Nephrotic syndrome (NS) is a common renal disease in the pediatric population, which can be complicated with
venous thromboembolic events.
Objectives: In the present study, the researchers evaluated the risk factors of venous thrombotic events in children with nephrotic
syndrome.
Methods: In this descriptive cross sectional study, the researchers evaluated 43 cases of NS including 35 uncomplicated and eight
complicated patients with venous thrombotic events, who were admitted to the nephrology ward of Ali-Asghar Children Hospi-
tal from 2011 to 2015. Two groups were matched for age onset of NS. Data were recorded on age, gender, body mass index (BMI),
histopathologic varieties of NS, and serum albumin level.
Results: The mean age of cases with venous thrombotic events was 7.31 ± 4.1 years. There were six females. Of eight cases with ve-
nous thrombotic events, five cases suffered of pulmonary thromboembolism (PTE) and five cases of deep vein thrombosis (DVT).
The mean serum albumin level in the thrombotic group was 1.87 ± 0.4 g/dL. The histopathologic results showed two cases of mem-
branous proliferative glomerulonephritis (MPGN), three cases of minimal change disease (MCD) and one case of focal segmental
glomerulosclerosis (FSGS). The researchers found significant differences between mean serum albumin level and histopathologic
results in the case and control groups.
Conclusions: Venous thrombosis and pulmonary emboli are important complications in pediatric NS. The risk of VTE increases
with lower serum albumin level. The risk of VTE increases with lower serum albumin level. The researchers suggest the use of anti-
thrombotic agents as prophylaxis in nephrotic patients with serum albumin level of less than 2 g/dL.
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1. Background
Nephrotic syndrome (NS) is a disease defined as mas-
sive proteinuria, edema, hypoalbuminemia, and hyperlipi-
demia. It is associated with hypercoagulability and venous
thromboembolic events (VTEs). Thromboembolic events
are important complications of NS, including pulmonary
emboli (PE), deep vein thrombosis (DVT) and renal venous
thrombosis (RVT). The different parameters are known as
risk factors for VTEs. In the adult population, VTEs occur
more frequently in NS with membranous nephropathy, in
the first six months of disease presentation, in cases with
low serum albumin level, antithrombin activity deficiency,
and high level of ionized calcium. Most studies regard-
ing thromboembolic events in NS patients are done on the
adult population and there are a few studies on children
(1-6).
2. Objectives
This study aimed at determining demographic,
histopathologic, and laboratory findings in children with
NS complicated by VTE.
3. Methods
This was a descriptive cross sectional study includ-
ing eight cases of idiopathic nephrotic syndrome admit-
ted to the nephrology ward of Ali-Asghar Children’s Hos-
pital of Tehran, Iran from 2011 to 2015. They had VTE as
an NS complication. Diagnosis of idiopathic NS was done
by the center nephrologist due to clinical manifestation
of edema, hypercholesterolemia, hypoalbuminemia, and
proteinuria more than 50 mg/kg per day. The secondary
NS and also the congenital NS cases were excluded. These
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cases were admitted because of the first presentation of
NS or due to its relapse. Another group of 35 primary idio-
pathic NS patients without VTE were chosen as the control
group. These two groups were matched according to the
mean age of disease onset.
Collected data included age, gender, BMI, serum albu-
min level (SAL), histopathologic result, and the sort of VTE.
All data were obtained from medical records and collected
through inventories. Statistical analysis was performed us-
ing SPSS V. 18. The student t-test and Pearson correlation
were employed for comparing variables. P values of less
than 0.05 were considered as significant. The project was
approved by the Ethics Committee of Iran University of
Medical Sciences.
4. Results
The mean age of onset of NS of the eight patients in the
case group was 3.81 years (± 2.6 y/o) and that of the control
group was 3.17 years (± 2.0 y/o) without a significant differ-
ence (P = 0.53). There was no significant difference between
the groups’ mean age and weights, and BMI (P = 0.05) (Ta-
ble 1).
The mean age of the case group at the study time was
7.3 years (± 4.1 y/o) and 4.7 (± 3.8 y/o) in the control group
and this difference was significant (P = 0.03). There were six
females in the case group (75%) and 15 females in the con-
trol group (43%). pulmonary emboli (PE) occurred in three
cases and five patients had deep vein thrombosis (DVT). No
case of renal vein thrombosis (RVT) was found. None of the
cases had VTE at the first six months of their NS presenta-
tion. The BMI in case and control groups were without a
significant difference. The mean serum albumin level in
the case group was 1.86 g/dL (± 0.4 g/dL) and in the con-
trol group, this was 2.41 g/dL (±0.4 g/dL) with a significant
difference (P = 0.01 and 95% CI: -0.91 and -0.15). There was a
Table 1. Demographic Features of Two Groups
Group N Mean ± SD Std. Error Mean
BMI
Case 8 18.35000 ± 2.5253005 0.8928286
Control 35 18.88000 ± 3.8615602 0.6527228
Weight
Case 8 27.62500 ± 12.4290846 4.3943450
Control 35 20.92857 ± 8.6080869 1.4550322
History
Case 8 2.00 ± 0.000 0.000
Control 35 1.97 ± 0.169 0.029
significant difference between groups’ mean albumin lev-
els (P = 0.05) (Table 2).
The histopathologic feature of focal segmental
glomerulosclerosis (FSGS), membranoproliferative
glomerulonephritis (MPGN) and minimal change dis-
ease (MCD) were distinguished in one, two, and three
cases in the VTE group, respectively (two cases did not
undergo renal biopsy), while in the control group, there
were eight FSGS, five MCD, and no MPGN with a significant
difference between these two groups (P = 0.01 and 0.01 for
FSGS and MPGN, respectively). The mean serum albumin
level in MPGN was lower than the other patients. Mean
albumin level was 1.60 ± 0.56 g/dL in the MPGN patients
yet in other pathologic varieties, the mean serum albumin
level was more than 2 g/dL (P = 0.05).
5. Discussion
Most studies about the frequency and risk factors of
VTEs in nephrotic syndrome have been done on adult pa-
tients and the studies in pediatric age group are scarce.
Study on pediatrics can make better insight on this group.
According to the results of this study, the mean age
of patients’ complicated with venous thrombosis is about
3.2 years more than nephrotic patients without VTE. This
shows that VTE in NS is not a frequent event at a very young
age and by increase in age, the rate of these events will be
more in nephrotic patients.
In the present study, the number of VTE in female pa-
tients was significantly more than male patients, while in
Ismail et al.’s study, the VTE were more frequent in male
adult patients. This needs bigger retrospective or prospec-
tive studies on pediatric and adult patients (7).
Table 2. Group Statistics; Mean Ages, Mean Albumin, and GFR Level
Group N Mean ± SD Std. Error Mean
Age
Case 8 7.31 ± 4.166 1.473
Control 35 4.60 ± 3.053 0.516
Age onset
Case 8 4.00 ± 2.646 0.935
Control 35 3.17 ± 2.083 0.352
GFR
Case 8 91.62 ± 28.804 10.184
Control 35 99.54 ± 18.979 3.208
ALB
Case 8 1.862500 ± 0.4867898 0.1721062
Control 35 2.400000 ± 0.4814195 0.0813747
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Serum albumin level in the thromboembolic group of
this study is significantly lower than the control group.
This finding is similar to other studies, mostly done on
adult patients (7-9). In the current study, the mean serum
albumin level of thromboembolic group was 1.87 g/dL.
Some studies consider serum albumin level less than 2.5
g/dL and some less than 1.5 g/dL as a higher risk for VTE (7,
10). This finding can suggest the use of intensification of
prophylactic anti-thrombotic treatment in nephrotic pa-
tients with severe hypoalbuminemia.
This study showed that there was a relationship
between the mean serum level of albumin and the
histopathologic varieties. As the results of this study found
that the mean serum albumin level in MPGN is less than
the other pathologic features, therefore there is greater
risk for VTE. Previous studies showed that membranous
nephritis (MN) is the most frequent variety that had a di-
rect relationship with VTE (10). This discrepancy between
the current study and previous studies could be due to the
population of studies; the current population of nephrotic
was children under 14 years old yet others were mostly on
adult populations, therefore, it seems that more studies
are needed on pediatric population.
Regarding the kind and site of VTE, some study results
on the adult population with NS, especially with membra-
nous nephropathy, have shown that renal vein thrombo-
sis is the most frequent VTE, especially in the presence of
severe hypoalbuminemia (9, 10) Zhang et al. showed that
35% of NS cases had PE or RVT. According to this study PE
were more common than RVT. Furthermore, PE in 84% of
cases was asymptomatic. According to this study, most PE
cases were asymptomatic and older age is a risk factor (11).
In Kayali et al.’s study, RVT is more common than PE in NS
(12). Li et al. in a study on 100 cases of NS, reported that RVT
is more common than PE. It seems that asymptomatic PE
cases were the reason of this discrepancy (13).
According to the current study, RVT did not occur. Ac-
cording to Medjeral-Thomas et al.’s study incidence of VTE
in MN is more than other forms of NS (14). This difference
between previous and the present study might be due to
the difference between the age of the population, as mem-
branous nephropathy in adults are frequent but not in pe-
diatrics.
5.1. Conclusions
The result of the current study showed that there is a
close relationship between serum albumin level and VTE
presentation in pediatric nephrotic syndrome. The re-
searchers could suggest the use of anti-thrombotic agents
as prophylaxis in nephrotic patients with serum albumin
level less than 2 g/dL. However, the limitation of the current
study was the number of patients with VTE. More studies in
this field on a larger pediatric population are needed.
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